var data={"title":"Brompheniramine and phenylephrine: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Brompheniramine and phenylephrine: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/7535?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=brompheniramine-and-phenylephrine-patient-drug-information\" class=\"drug drug_patient\">see &quot;Brompheniramine and phenylephrine: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7675109\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Brohist D [OTC];</li>\n      <li>BroveX PEB [OTC] [DSC];</li>\n      <li>Dimaphen Children's [OTC];</li>\n      <li>Dimetapp Children's Cold &amp; Allergy [OTC];</li>\n      <li>Entre-B [OTC];</li>\n      <li>Glenmax PEB [OTC];</li>\n      <li>LoHist PEB [OTC] [DSC];</li>\n      <li>Relhist BP [OTC];</li>\n      <li>Ru-Hist D [OTC];</li>\n      <li>Rynex PE [OTC];</li>\n      <li>Triaminic Cold &amp; Allergy [OTC];</li>\n      <li>Vazobid-PD [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7675112\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Alkylamine Derivative;</li>\n      <li>\n        Alpha-Adrenergic Agonist;</li>\n      <li>\n        Decongestant;</li>\n      <li>\n        Histamine H<sub>1</sub> Antagonist;</li>\n      <li>\n        Histamine H<sub>1</sub> Antagonist, First Generation</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7677174\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Upper respiratory tract conditions:</b> Oral: <b>Note:</b> These are general dosage guidelines; also refer to product specific dosing. All dosing is presented in terms of brompheniramine maleate and phenylephrine hydrochloride:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquid:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Brompheniramine 1 mg and phenylephrine 2.5 mg per 5 mL: 20 mL every 4 hours (maximum: 120 mL/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Brompheniramine 1.2 mg and phenylephrine 2 mg <b>per 1 mL</b>: 3 mL every 4 to 6 hours (maximum: 18 mL/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Brompheniramine 4 mg and phenylephrine 10 mg per 5 mL: 5 mL every 4 hours; (maximum: 30 mL/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablets: Brompheniramine 4 mg and phenylephrine 10 mg per tablet: 1 tablet every 4 hours (maximum: 6 tablets in 24 hours)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7677173\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Upper respiratory tract conditions:</b> Oral: <b>Note:</b> These are general dosage guidelines; also refer to product specific dosing. All dosing is presented in terms of brompheniramine maleate and phenylephrine hydrochloride:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Liquid:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 2 to &lt;6 years: Brompheniramine 1 mg and phenylephrine 2.5 mg per 5 mL: 5 mL every 4 hours (maximum: 30 mL/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 6 to 11 years:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Brompheniramine 1 mg and phenylephrine 2.5 mg per 5 mL: 10 mL every 4 hours (maximum: 60 mL/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Brompheniramine 1.2 mg and phenylephrine 2 mg <b>per 1 mL</b>: 1.5 mL every 4 to 6 hours (maximum: 9 mL/24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Tablets:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 6 to 11 years: Brompheniramine 4 mg and phenylephrine 10 mg per tablet: One-half tablet every 4 hours (maximum: 3 tablets in 24 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;12 years and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7677823\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50484738\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50484739\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F239199\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquid, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">BroveX PEB: Brompheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg per 5 mL (473 mL [DSC]) [dye free, ethanol free, gluten free, sugar free; contains propylene glycol; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dimaphen Children's: Brompheniramine maleate 1 mg and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL, 237 mL) [ethanol free, gluten free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dimetapp Children&rsquo;s Cold &amp; Allergy: Brompheniramine maleate 1 mg and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL, 237 mL) [ethanol free; contains sodium 3 mg/5 mL, propylene glycol, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Glenmax PEB: Brompheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg per 5 mL (473 mL) [alcohol free, dye free, sugar free; contains propylene glycol, saccharin sodium, sodium benzoate, sorbitol; fruit gum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">LoHist PEB: Brompheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg per 5 mL (473 mL [DSC]) [dye free, ethanol free, sugar free; contains propylene glycol, sodium benzoate; bubble gum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Rynex PE: Brompheniramine maleate 1 mg and phenylephrine hydrochloride 2.5 mg per 5 mL (473 mL) [ethanol free, gluten free, sugar free; contains propylene glycol; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suspension, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Entre-B: Brompheniramine maleate 6 mg and phenylephrine hydrochloride 10 mg per 5 mL (118 mL) [contains benzoic acid, propylene glycol; bubble gum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vazobid-PD: Brompheniramine maleate 1.2 mg and phenylephrine hydrochloride 2 mg per 1 mL (118 mL) [contains aspartame, sodium benzoate; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Syrup, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Cold &amp; Allergy: Brompheniramine maleate 1 mg and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL) [contains propylene glycol, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Brohist D: Brompheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Relhist BP: Brompheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ru-Hist D: Brompheniramine maleate 4 mg and phenylephrine hydrochloride 10 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7675111\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7677176\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Measure liquid doses using provided dosage cup only.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F239200\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Upper respiratory tract conditions:</b> Temporary relief of symptoms (nasal congestion; runny nose; sneezing; itching of the eyes, nose, or throat) associated with the common cold, allergic rhinitis (hay fever), and other upper respiratory tract conditions</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46056526\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Geriatric Patients: High-Risk Medication:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Beers Criteria: Brompheniramine, a first-generation antihistamine, is identified in the Beers Criteria as a potentially inappropriate medication to be avoided in patients 65 years and older (independent of diagnosis or condition) due to its potent anticholinergic properties resulting in increased risk of confusion, dry mouth, constipation, and other anticholinergic effects or toxicity; use should also be avoided due to reduced clearance with advanced age and tolerance associated with use as a hypnotic (Beers Criteria [AGS 2015]).</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F239195\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F239202\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Use with or within 14 days of MAO inhibitor therapy; do not use to sedate a child</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F239193\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (including hypertension).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Diabetes: Use with caution in patients with diabetes mellitus.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Increased intraocular pressure/glaucoma: Use with caution in patients with increased intraocular pressure or glaucoma.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pyloroduodenal obstruction: Use with caution in patients with pyloroduodenal obstruction (including stenotic peptic ulcer).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Respiratory disease: Use with caution in patients with asthma or other chronic breathing disorders.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Antihistamines may cause excitation in young children. Do not exceed pediatric dosing recommendations. If no recommendations exist on OTC labeling for patient's age, the product should <b>not</b> be administered without the guidance of a physician.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions: </i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Self-medication (OTC use): When used for self medication (OTC), notify healthcare provider if symptoms do not improve within 7 days or are accompanied by fever. Discontinue and contact healthcare provider if nervousness, dizziness, or sleeplessness occur.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7677175\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some products contain sodium.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7677170\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:0em;display:inline\">See individual agents.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16324138\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Relhist Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">6-15 mg (60): $128.40</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Elixir</b> (Decon-A Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2-5 mg/5 mL (118 mL): $10.20</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Elixir</b> (Dimetapp Cold/Allergy Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2.5 mg/5 mL (118 mL): $5.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Decon-A Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2-5 mg/mL (30 mL): $10.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Vazobid-PD Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">6-10 mg/5 mL (118 mL): $40.77</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Triaminic Cold &amp; Allergy Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1-2.5 mg/5 mL (118 mL): $5.44</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Relhist BP Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4-10 mg (60): $41.27</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50470350\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Asiatapp (TH);</li>\n      <li>Bepeno (TH);</li>\n      <li>Bialerge (BR);</li>\n      <li>Bromesep (TH);</li>\n      <li>Bromitapp (PH);</li>\n      <li>Centapp (TH);</li>\n      <li>Decongex Plus (BR);</li>\n      <li>Dimetapp (AU, HK, MX, PH, SG, TH);</li>\n      <li>Leffrin (TH);</li>\n      <li>Nazaclir (PH);</li>\n      <li>Respitapp (PH);</li>\n      <li>Rhinobol (CN);</li>\n      <li>Snizee (PH);</li>\n      <li>Sunulif (PH);</li>\n      <li>Unihist (HK, MY, TH)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults [published online October 8, 2015]. <i>J Am Geriatr Soc</i>. 2015;63(11):2227-2246. doi:10.1111/jgs.13702.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/brompheniramine-and-phenylephrine-drug-information/abstract-text/26446832/pubmed\" target=\"_blank\" id=\"26446832\">26446832</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dimaphen (phenylephrine hydrochloride and brompheniramine maleate liquid) [prescribing information]. Livonia, MI: Major Pharmaceuticals; May 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Glenmax PEB (phenylephrine hydrochloride and brompheniramine maleate syrup) [prescribing information]. Villa Park, IL: Glendale Inc.; December 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Relhist BP (brompheniramine maleate and phenylephrine hydrochloride) [prescribing information]. Richland, MS: Burel Pharmaceuticals; November 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rynex PE (brompheniramine maleate and phenylephrine hydrochloride liquid) [prescribing information]. Ripley, MS: Edwards Pharmaceuticals, Inc.; April 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Taverner D, Latte J. Nasal decongestants for the common cold. <i>Cochrane Database Syst Rev</i>. 2007;(1):CD001953.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/brompheniramine-and-phenylephrine-drug-information/abstract-text/17253470/pubmed\" target=\"_blank\" id=\"17253470\">17253470</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Triaminic Cold and Allergy (brompheniramine maleate and phenylephrine hydrochloride syrup) [prescribing information]. Parsippany, NJ: Novartis Consumer Health, Inc.; October 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vazobid PD (brompheniramine maleate and phenylephrine hydrochloride liquid) [prescribing information]. Ridgeland, MS: WraSer Pharmaceuticals, LLC; December 2011.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9070 Version 79.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F7675109\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F7675112\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F7677174\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F7677173\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F7677823\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F50484738\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F50484739\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F239199\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F7675111\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F7677176\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F239200\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F46056526\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F239195\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F239202\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F239193\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F7677175\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F7677170\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16324138\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F50470350\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9070|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=brompheniramine-and-phenylephrine-patient-drug-information\" class=\"drug drug_patient\">Brompheniramine and phenylephrine: Patient drug information</a></li></ul></div></div>","javascript":null}